View in EDS HTML Full Text PDF Full Text

Development of AL101 (GSK4527226), a progranulin-elevating monoclonal antibody, as a potential treatment for Alzheimer's disease.

Saved in:

Bibliographic Details
Title:	Development of AL101 (GSK4527226), a progranulin-elevating monoclonal antibody, as a potential treatment for Alzheimer's disease.
Authors:	Budda, Balasubrahmanyam¹ (AUTHOR) balasubrahmanya.budda@alector.com, Mitra, Ananya¹ (AUTHOR), Park, Lovingly¹ (AUTHOR), Long, Hua¹ (AUTHOR), Kurnellas, Michael² (AUTHOR), Bien-Ly, Nga¹ (AUTHOR), Estacio, William³ (AUTHOR), Burgess, Brady¹ (AUTHOR), Chao, Grace¹ (AUTHOR), Schwabe, Tina⁴ (AUTHOR), Paul, Robert⁴ (AUTHOR), Kenkare-Mitra, Sara¹ (AUTHOR), Rosenthal, Arnon¹ (AUTHOR)
Source:	Alzheimer's Research & Therapy. 7/25/2025, Vol. 17 Issue 1, p1-21. 21p.
Database:	Academic Search Ultimate
Full text is not displayed to guests. Login for full access.

Be the first to leave a comment!